Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10014451292
The empirical literature on the asset allocation and medical expenditures ofU.S. households consistently shows that risky portfolio shares are increasing inboth wealth and health whereas health investment shares are decreasing in thesesame variables. Despite this evidence, most of the existing...
Persistent link: https://www.econbiz.de/10005868769
Richer and healthier agents tend to hold riskier portfolios and spend proportionally less on health expenditures. Potential explanations include health and wealth e ffects on preferences, expected longevity or disposable total wealth. Using HRS data, we perform a structural estimation of a...
Persistent link: https://www.econbiz.de/10008797085
Health insurance status can change over the life cycle for exogenous reasons (e.g. Medicare for the elders, PPACA for younger agents, termination of coverage at retirement in employer-provided plans). Durability of the health capital, endogenous mortality and morbidity, as well as backward...
Persistent link: https://www.econbiz.de/10010412774
Persistent link: https://www.econbiz.de/10013188609
Near the end of life, health declines, mortality risk increases and curative is replaced by uninsured long-term care, accelerating the fall in wealth. Whereas standard explanations emphasize inevitable aging processes, we propose a com- plementary closing down the shop justification where...
Persistent link: https://www.econbiz.de/10011627127
Persistent link: https://www.econbiz.de/10011588882
Persistent link: https://www.econbiz.de/10012105202
Lifetime financial-, work- and health-related decisions made by agents are intertwined with one another. Understanding how these decisions are made is essential to gauge if saving in financial, retirement and human assets is adequate or not. This paper numerically solves, simulates, and...
Persistent link: https://www.econbiz.de/10011619243
The Human Capital (HK) and Statistical Life Values (VSL) differ sharply in their empirical pricing of a human life and lack a common theoretical background to justify these differences. We first contribute to the theory and measurement of life value by providing a unified framework to formally...
Persistent link: https://www.econbiz.de/10011899606